What Is HMG? HMG, short for Human Menopausal Gonadotropin, is a type of gonadotropin hormone preparation with important applications in reproductive medicine and health management.
How It Works?
Receptor Targeting & Activation
Mechanism in Females (Ovulation Induction)
Mechanism in Males (Spermatogenesis Support)
Key Features & Benefits
1. For Female Reproductive Health (Infertility & ART)
Induces Controlled Folliculogenesis: Stimulates the growth and maturation of ovarian follicles, addressing anovulation (lack of ovulation) caused by gonadotropin deficiency or polycystic ovary syndrome (PCOS) subtypes.
Supports Ovulation Triggering: Works with hCG to trigger final follicle rupture and oocyte release, enabling timed intercourse or ART procedures (e.g., egg retrieval for IVF).
Enhances Early Pregnancy Support: Promotes corpus luteum formation and progesterone secretion, improving the uterine lining’s receptivity for embryo implantation.
2. For Male Reproductive Health (Spermatogenesis Support)
Facilitates Sperm Maturation: FSH stimulates Sertoli cells to produce androgen-binding protein (ABP), creating the optimal microenvironment for spermatid maturation and improving sperm count/motility in cases of male factor infertility (e.g., hypogonadotropic hypogonadism).
3. Clinical & Formulation Advantages
Broad Infertility Indications: Treats a range of reproductive disorders, including hypogonadotropic hypogonadism, anovulatory infertility, and male oligozoospermia (low sperm count).
High Safety Profile: Recombinant HMG minimizes adverse reactions linked to urinary impurities; side effects (e.g., ovarian hyperstimulation syndrome, mild pelvic pain) are manageable with dose adjustment and monitoring.
Consistent Efficacy: rHMG’s standardized FSH/LH ratio reduces treatment variability, improving success rates in ART cycles compared to older urinary formulations.
Applications 1. Female Reproductive Health
Treats anovulatory infertility (e.g., gonadotropin deficiency, select PCOS cases) by stimulating follicle maturation and restoring ovulation.
Supports luteal phase function to improve embryo implantation and reduce early pregnancy loss.
Induces ovulation for timed intercourse or intrauterine insemination (IUI).
2. Male Reproductive Health
Manages hypogonadotropic hypogonadism by boosting testosterone production (via LH) and supporting testicular development.
Improves sperm count/motility in male factor infertility (e.g., oligozoospermia) by optimizing spermatid maturation (via FSH).
2. Assisted Reproductive Technologies (ART)
Prepares multiple mature oocytes for IVF/ICSI cycles by stimulating multi-follicle growth, raising embryo yield and ART success rates.
Enables egg cryopreservation for fertility preservation in women facing gonadotoxic treatments (e.g., chemotherapy).
